Uncategorised - Page 2

Tourette Syndrome Pipeline 2026: Investigational Therapies, Clinical Trial Advances, and Key Regulatory Developments by DelveInsight

According to DelveInsight’s latest evaluation, the global Tourette syndrome treatment pipeline features more than 6 prominent companies actively advancing over 6 investigational therapies. The comprehensive assessment covers ongoing clinical trials, therapeutic candidates, mechanisms of action, administration routes, and notable developmental milestones. The

25 March 2026

Uncategorised

Psoriasis Market: Steady Growth Driven by Advancements in Biologic and Oral Therapies by 2034

DelveInsight’s “Psoriasis Market Insights, Epidemiology, and Market Forecast-2034“ report offers an in-depth understanding of psoriasis, including historical and forecasted epidemiology, market trends, treatment practices, and emerging therapies across the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.

8 October 2026

Uncategorised

Vaccine Contract Manufacturing Market to Grow as Rising Vaccine Demand Drives Global Production Expansion

Vaccine Contract Manufacturing Market Summary The global Vaccine Contract Manufacturing market was valued at approximately USD 2,282.36 million in 2024 and is projected to reach nearly USD 3,905.96 million by 2032, growing at a CAGR of 6.9% during 2025–2032. The market is

7 October 2026

Uncategorised

Polycystic Ovary Syndrome Market Set for Growth as Rising Diagnosis and Novel Therapies Shape Women’s Health Landscape

Polycystic Ovary Syndrome Market Summary The Polycystic Ovary Syndrome (PCOS) market is expected to witness continued growth through 2034, supported by increasing disease awareness, improving diagnosis, a large treated population, and persistent unmet medical needs. The market is currently dominated by symptomatic

7 October 2026

Uncategorised

Aplastic Anemia Market to Cross USD 300 Million by 2036 Amid Steady Reliance on Immunosuppressive Therapies and Emerging Cell-Based Approaches

DelveInsight’s “Aplastic Anemia Market Insights, Epidemiology, and Market Forecast 2036” report provides comprehensive insights into the Aplastic Anemia market size, historical and forecasted epidemiology, current and emerging treatment landscape, and market opportunity across the 7MM, including the United States, EU4 (Germany, France,

7 October 2026

Uncategorised

Marginal Zone Lymphoma Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight

(Las Vegas, Nevada, United States) As per DelveInsight’s evaluation, globally, the Marginal Zone Lymphoma (MZL) pipeline consists of 50+ leading companies actively working to develop 50+ MZL treatment therapies, covering clinical trials, therapeutic approaches, mechanisms of action, routes of administration, and ongoing

6 October 2026

Uncategorised

Alcohol Use Disorder Market Outlook Shows Significant Expansion Across the 7MM Through 2036

DelveInsight’s “Alcohol Use Disorder – Market Insights, Epidemiology, and Market Forecast – 2036“ report offers an in-depth understanding of AUD, historical and forecasted epidemiology, as well as the market trends in the United States, EU4 (Germany, Spain, Italy, and France), the United

28 September 2026

Uncategorised

Immune Checkpoint Inhibitors Market Growth Driven by Innovation, Oncology Expansion, and Immunotherapy Adoption

Immune Checkpoint Inhibitors Market Overview The immune checkpoint inhibitors market is becoming an increasingly important segment of the global oncology landscape as cancer treatment continues to shift toward targeted and immune-mediated approaches. Immune checkpoint inhibitors are designed to block inhibitory pathways that

25 September 2026

Uncategorised

NASH Market Growth Driven by Emerging Therapies Diagnostics and Biomarker Innovation

Nonalcoholic Steatohepatitis Market Landscape and Emerging Opportunities Nonalcoholic steatohepatitis (NASH), a progressive form of metabolic liver disease, is attracting increasing attention because of its association with liver inflammation, hepatocyte injury, fibrosis, cirrhosis, and potentially end-stage liver disease. DelveInsight estimates that the NASH

24 September 2026

Uncategorised

The Global Biologics Market is growing at a CAGR of 9.54% by 2034, estimates DelveInsight

DelveInsight’s Biologics Market Insights Report 2034 provides the current and forecast market analysis, individual leading Biologics Companies market shares, challenges, Biologics Market Drivers, barriers, trends, and key Biologics Companies shaping the global market landscape. The report delivers comprehensive insights into market dynamics,

24 September 2026

Uncategorised

Plexiform Neurofibroma Market Growth Driven by Targeted Therapies and Rising Disease Awareness

Plexiform Neurofibromas Burden and Market Landscape Plexiform neurofibromas are benign tumors that arise from peripheral nerves and are strongly associated with Neurofibromatosis Type 1 (NF1), a genetic disorder affecting the nervous system. These tumors can develop along nerve sheaths and infiltrate surrounding

23 September 2026

Previous 1 2 3 4 … 39 Next

Uncategorised - Page 2

Tourette Syndrome Pipeline 2026: Investigational Therapies, Clinical Trial Advances, and Key Regulatory Developments by DelveInsight

Psoriasis Market: Steady Growth Driven by Advancements in Biologic and Oral Therapies by 2034

Vaccine Contract Manufacturing Market to Grow as Rising Vaccine Demand Drives Global Production Expansion

Polycystic Ovary Syndrome Market Set for Growth as Rising Diagnosis and Novel Therapies Shape Women’s Health Landscape

Aplastic Anemia Market to Cross USD 300 Million by 2036 Amid Steady Reliance on Immunosuppressive Therapies and Emerging Cell-Based Approaches

Marginal Zone Lymphoma Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight

Alcohol Use Disorder Market Outlook Shows Significant Expansion Across the 7MM Through 2036

Immune Checkpoint Inhibitors Market Growth Driven by Innovation, Oncology Expansion, and Immunotherapy Adoption

NASH Market Growth Driven by Emerging Therapies Diagnostics and Biomarker Innovation

The Global Biologics Market is growing at a CAGR of 9.54% by 2034, estimates DelveInsight

Plexiform Neurofibroma Market Growth Driven by Targeted Therapies and Rising Disease Awareness

Recent Posts

Banner

Newsletter

Authors

pharmaglobenews

Michael Ashford

NCFB Market on the Brink of Change as First DPP1 Inhibitor Marks Approval | DelveInsight

Suggestions

Uncategorised - Page 2

Recent Posts

Banner

Newsletter

Authors